Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation of Brain Function in Alzheimer's Disease and Related Dementias

NCT06538311 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06538311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation of Brain Function in Alzheimer's Disease and Related Dementias
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
May 1, 2023
Completion date
March 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, amnestic symptoms, logopenic progressive aphasia, mild cognitive impairment